ClinicalTrials.gg
Not yet recruitingNCT07677761Updated Jul 1, 2026

Manual Lymphatic Drainage on Pressure Injuries

An interventional study of Experimental and Control in Pressure Injuries and MANUEL LENFATIK DRENAJ, sponsored by Rukiye Kokkiz. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-01.

Sponsored by Rukiye Kokkiz · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Primary completion was expected by Aug 2026, 3 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Pressure injuries are a significant health problem, often resulting from pressure, friction, and impaired tissue perfusion, and are particularly common in individuals in intensive care, those with immobility, and those with chronic diseases. The literature extensively addresses interventions such as pressure reduction, the use of appropriate support surfaces, wound care practices, and nutritional support in the prevention and treatment of pressure injuries. However, the role of manual therapies aimed at improving circulation and lymphatic flow, such as manual lymphatic drainage (MLD), in pressure injuries has been examined in a limited number of studies. This research aims to fill a significant gap in the literature by evaluating the potential effects of manual lymphatic drainage on reducing edema, improving tissue perfusion, and supporting the wound healing process in individuals with pressure injuries.

02

Conditions studied

  • Pressure Injuries
  • MANUEL LENFATIK DRENAJ

Browse trials for

03

In context

Pressure Ulcer

545 studies on the registry are indexed under Pressure Ulcer; 129 are open to participants now.

This study's planned enrollment of 60 is below the median of 70 across 405 interventional studies indexed under Pressure Ulcer.

Browse Pressure Ulcer studies →

Lead sponsor

Rukiye Kokkiz is the lead sponsor of 3 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Presence of pressure injury in the sacrum region
  • Volunteer to participate in the study
  • Being over 18 years of age
  • Being hospitalized in the anesthesia intensive care unit

Exclusion criteria

Exclusion Criteria:

  • Chronic illness that may affect pressure injury healing (malnutrition, hypertension, and diabetes)
  • Discharge during the investigation process
  • Death during the investigation process
  • Acute cellulitis
  • Severe heart failure
  • Renal failure
  • Tuberculosis
  • Superior vena cava obstruction
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Manual lymphatic drainage group

    Individuals will be randomly assigned to intervention and control groups in a 1:1 ratio via the website random.org. The Bates-Jensen Wound Assessment Tool will be administered to all individuals by the researchers. The size of the wound (length\*depth\*width) will be measured and recorded. Standard care will be applied to the control group. The experimental group will receive standard care along with manual lymphatic drainage according to the protocol below. Afterwards, the Bates-Jensen Wound Assessment Tool will be administered to all individuals by the researchers, and the size of the wound (length\*depth\*width) will be measured and recorded.

    Other: Experimental

  • Active comparator
    comparison group

    Other: Control

Interventions

  • OtherExperimental

    Individuals will be randomly assigned to intervention and control groups in a 1:1 ratio via the website random.org. The Bates-Jensen Wound Assessment Tool will be administered to all individuals by the researchers. The size of the wound (length\*depth\*width) will be measured and recorded. Standard care will be applied to the control group. The experimental group will receive standard care along with manual lymphatic drainage according to the protocol below. Afterwards, the Bates-Jensen Wound Assessment Tool will be administered to all individuals by the researchers, and the size of the wound (length\*depth\*width) will be measured and recorded.

  • OtherControl

    Standard care practices will include regular position changes for patients, use of supportive surfaces to reduce pressure, maintenance of skin integrity, and keeping the wound area clean. Wound cleaning will be performed with sterile solutions, appropriate debridement methods will be applied in the presence of necrotic tissue, and suitable dressing materials will be selected according to the condition of the wound bed. In addition, patients' nutritional status, hydration level, and signs of infection will be regularly assessed, and necessary supportive treatments will be provided.

06

What researchers measure

Primary outcomes

  1. Effect of manual lymphatic drainage

    The primary aim of this study is to evaluate the effect of manual lymphatic drainage on the healing level of pressure injuries. Wound healing will be assessed considering the wound stage (Stage 1-2-3-4, unstageable stage, and deep tissue injury) and size (length\*width\*depth).

    Time frame: 3 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07677761
Lead sponsor
Rukiye Kokkiz
Responsible party
Rukiye Kokkiz (LECTURER, Fenerbahce University) — Sponsor-investigator
First posted
Jul 1, 2026
Start date
Jul 1, 2026 (estimated)
Primary completion
Aug 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Jul 1, 2026

Study contacts

rukiye kökkız, LECTURER
Contact
rky_kokkiz@hotmail.com
+90 507 140 68 98

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion